Medicine recalls
|
| |
| Canada: Recall: JAMP-Pregabalin: One lot recalled as some bottles may contain 150 mg capsules |
| |
Health Canada announces that JAMP Pharma Corporation is recalling one lot of JAMP-Pregabalin 50mg Capsules (lot number: 2305012747) from retailers because the affected lot (JAMP-Pregabalin 50mg) may contain capsule(s) of JAMP-Pregabalin 150mg.
JAMP-Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia and spinal cord injury. It is also indicated for the management of pain associated with fibromyalgia.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/jamp-pregabalin-one-lot-recalled-some-bottles-may-contain-150-mg-capsules
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Tuesday, May 6, 2025
Issued at HKT 16:30
|
| |
